AYTU BioPharma, Inc. Common Stock

AYTUNASDAQ • USD
2.10 USD
↗ 0.03 (1.45%)🟢LIVE (AS OF 03:22 PM EDT)
🟢Market: OPEN

Shares of AYTU BioPharma, Inc. Common Stock (AYTU) are trading at $2.10. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 2, 2026.

Open?$2.05
High?$2.17
Low?$2.05
Prev. Close?$2.07
Volume?53.3K
Avg. Volume?42.0K
VWAP?$2.09
Rel. Volume?1.27x
Bid / Ask
Bid?$1.78 × 100
Ask?$2.46 × 100
Spread?$0.68
Midpoint?$2.12
Valuation & Ratios
Market Cap?22.5M
Shares Out?10.9M
Float?9.1M
Float %?85.0%
P/E Ratio?N/A
P/B Ratio?0.64
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
Employees
76
Market Cap
22.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2008-02-15
Address
7900 E. UNION AVENUE
DENVER, CO 80237
Phone: (720) 437-6580
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
43
Short Sent.?
41
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.08Distress
Confidence?57%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?3.41%Low
Short Interest?311.6K
Days to Cover?12.9
Free Float9.1M
Avg Daily Volume24.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.13Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.48Low
Debt/Equity?0.48Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.64CHEAP▾
P/S?
Peers
100
S&P
97
0.39CHEAP▾
P/FCF?
Peers
100
S&P
97
6.9CHEAP▾
EV/EBITDA?
S&P
97
-3.0CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.23CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-40.4%WEAK▾
ROA?
S&P
3
-13.6%WEAK▾
Cash Flow & Enterprise
FCF?$3.3M
Enterprise Value?$13.2M
Fundamentals ratios updated end of day